Enhancing patient acceptance of ICD implantation through structured shared decision making

Published in the Journal of Interventional Cardiac Electrophysiology, this study conducted by Ipsos leveraged cutting-edge AI-enabled video analytics technology that not only assessed spoken content but also analyzed individuals’ expressions and body movement together with patient sentiments.

Background

Implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-D) are lifesaving treatments for patients at risk for sudden cardiac death. Effective physician–patient communication during the shared decision-making process is essential. Electrophysiologist-patient conversations were targeted to obtain objective data on the interaction, understand the conversation framework, and uncover opportunities for improved communication.

Methods

Individuals previously identified as requiring an ICD/CRT-D but declined implantation were recruited for this four-stage interview and survey-based study. Quantitative analysis of surveys and AI analysis of conversation videos was conducted to evaluate patient participant expectations, analyze feedback about the conversations with study physicians, and gauge willingness for device implantation.

Conclusions

In a cohort of patients who previously declined ICD/CRT-D implantation, patient satisfaction and willingness to undergo implantation of a guideline-directed device therapy increased significantly following a structured conversation with study physicians. Identified key elements could be integrated into user-friendly tools and educational materials to facilitate these conversations, improving patient engagement with the decision-making process and enhancing informed acceptance of indicated device therapies.

Access the full report here.

The author(s)

Related news

  • Automotive Disruption and Trends Webinar
    Consumers Webinar

    Automotive Disruption and Trends Webinar

    Please join Ipsos and SAA for a discussion on the future of mobility based on insights from the 2025 Ipsos Navigator Study.
  • Obesity Week

    Obesity Week

    This is a conference that encompasses the full spectrum of obesity science: from basic science research, to translational research and clinical application, to public policy; from diet, exercise, lifestyle, and psychology to medical and surgical interventions; from pediatric to geriatric to underserved populations.
  • EPHMRA: Human Factors for Devices & Drugs

    EPHMRA: Human Factors for Devices & Drugs

    Ipsos is delighted to join EPHMRA for a 45-minute webinar discussion that will move beyond the basics to explore the application of HF research today.